First-trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction

Prenatal Diagnosis

Volumn 30, Issue 4, 2010, Pages 372-377

  Engels, M A J ^a   Kooij, M ^a   Schats, R ^a   Twisk, J W R ^a   Blankenstein, M A ^a   Van Vugt, J M G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Assisted reproduction; Down syndrome; First trimester screening; Free hCG; Nuchal translucency thickness; PAPP A

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MATERNAL AGE; MATERNAL SERUM; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; REFERENCE STANDARDS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 77950633362     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2495     Document Type: Article

References (39)

1. Aboulgar H, Aboulghar M, Mansour R, Serour G, Amin Y, Al-Inany H. 2001. A prospective controlled study of karyotyping for 430 consecutive babies conceived through intracytoplasmic sperm injection. Fertil Steril 76: 249-253.
2. Allen VM, Wilson RD, Cheung A. 2006. Pregnancies outcomes after assisted reproductive techniques. J Obstet Gynaecol Can 28: 220-250.
3. Bellver J, Lara C, Soares SR, et al. 2005. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod 20: 623-2627.
4. Bersinger NA, Wunder D, Vanderlick F, et al. 2004. Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening. Prenat Diagn 24: 471-477.
5. Bettio D, Venci A, Levi Setti PE. 2008. Chromosomal abnormalities in miscarriages after different assisted reproduction procedures. Placenta 29(Suppl. B): 126-128.
6. Bonduelle M, Van Assche E, Joris H, et al. 2002. Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod 17: 2600-2614.
7. De Graaf IM, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, van Lith JM. 2000. Co-variables in first trimester maternal serum screening. Prenat Diagn 20: 186-189.
8. Evans MI, Andriole S. 2008. Chorionic villus sampling and amniocentesis in 2008. Curr Opin Obstet Gynecol 20: 164-168.
9. Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN. 1997. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 90: 98-101.
10. Gagnon A, Wilson RD, Audibert F, et al, Society of Obstetricians and Gynaecologists of Canada Genetics Committee. 2008. Obstetrical complications associated with maternal serum markers analytes. J Obstet Gynecol Can 30: 948-949.
11. Ghisoni L, Ferrazzi E, Castagna C, Levi Setti PE, Masini AC, Pigni A. 2003. Prenatal diagnosis after ART success: the role of early combined screening tests in counselling pregnant patients. Placenta 24(Suppl. B): S99-S103.
12. Gjerris AC, Loft A, Pinborg A, Christiansen M, Tabor A. 2009. Firsttrimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol 33: 8-17.
13. Go AT, Hupkes HW, Lomecky M, Twisk J, Blankenstein JM, van Vugt JM. 2005. Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy. Ned Tijdschr Geneeskd 149: 2795-2799.
14. Hui PW, Lam YH, Tang MH, NG EH, Yeung WS, Ho PC. 2005a. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection. Prenat Diagn 25: 390-393.
15. Hui PW, Tang MHY, Lam YH, Yeung WSB, NG EHY, Ho PC. 2005b. Nuchal translucency in pregnancies conceived after assisted reproduction technology. Ultrasound Obstet Gynecol 25: 234-238.
16. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. 2008. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 31: 618-624.
17. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. 2008. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31: 493-502.
18. Koulischer L, Verloes A, Lesenfants S, Jamar M, Herens C. 1997. Genetic risk in natural and medically assisted procreation. Early Pregnancy 3: 164-171.
19. Lambert-Messerlian G, Dugoff L, Vidaver J, et al. 2006. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study. Prenat Diagn 26: 672-678.
20. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. 2001. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 16: 1501-1504.
21. Linskens IH, Levitus M, Frans A, et al. 2009. Performance of free beta-human chorionic gonadotrophin (free beta-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands. Clin Chem Lab Med 47: 222-226.
22. Maymon R, Jauniaux E. 2002. Down's syndrome screening in pregnancies after assisted reproductive techniques: an update. Reprod Biomed Online 4: 285-293.
23. Maymon R, Shulman A. 2004. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 24: 125-129.
24. Nicolaides KH. 2004. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 191: 45-67.
25. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. 2000. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 107: 1265-1270.
26. Orlandi F, Rossi C, Allegra A, et al. 2002. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 22: 718-721.
27. Roseboom TJ, Vermeiden JP, Schoute E, Lens JW, Schats R. 1995. The probability of pregnancy after embryo transfer is affected by the age of the patient, cause of infertility, number of embryos transferred and the average morphology score, as revealed by multiple logistic regression analysis. Hum Reprod 10: 3035-3041.
28. Räty R, Virtanen A, Koskinen P, et al. 2002. Serum free β-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome. Hum Reprod 17: 481-484.
29. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. 2002. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87: 1762-1767.
30. Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH. 2008a. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 31: 147-152.
31. Spencer K, Cowans NJ, Avgidou K, Molina F, Nicolaides KH. 2008b. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 31: 15-19.
32. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein- A. Ultrasound Obstet Gynecol 13: 231-237.
33. Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH. 2005. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 25: 365-369.
34. Tul N, Novak-Antolic Z. 2006. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Prenat Diagn 26: 1206-1211.
35. Wald NJ, White N, Morris JK, Huttly WJ, Canick JA. 1999. Serum markers for Down's syndrome in women who have had in vitro fertilization: implications for antenatal screening. Br J Obstet Gynaecol 106: 1304-1306.
36. Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. 2005. SURUSS in perspective. Semin Perinatol 29: 225-235.
37. Wapner R, Thom E, Simpson JL, et al, for the First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. 2003. First-trimester screening for trisomies 13 and 18. New Engl J Med 349: 1405-1413.
38. Wøjdemann KR, Larsen SO, Shalmi A, Sundberg K, Christiansen M, Tabor A. 2001. First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 21: 563-565.
39. Yu Ng EH, Yeung WS, Yee Lan LE, So WW, Ho PC. 2000. High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles. Hum Reprod 15: 250-255.